(Q48258765)

10 February 2018

title

Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests. (English)

1 reference

10 February 2018

5

Matthias Lubnow

1 reference

10 February 2018

author name string

Carsten G Jungbauer

1

1 reference

10 February 2018

Bernhard Kaess

2

1 reference

10 February 2018

Stefan Buchner

3

1 reference

10 February 2018

Christoph Birner

4

1 reference

10 February 2018

Markus Resch

6

1 reference

10 February 2018

Kurt Debl

7

1 reference

10 February 2018

Monika Buesing

8

1 reference

10 February 2018

Rainer Zerback

9

1 reference

10 February 2018

Günter Riegger

10

1 reference

10 February 2018

Andreas Luchner

11

1 reference

10 February 2018

publication date

1 December 2012

1 reference

10 February 2018

published in

Biomarkers in Medicine

1 reference

10 February 2018

volume

6

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

789-796

1 reference

10 February 2018

N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea.

cites work

1 reference

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease

21 January 2018

1 reference

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers

21 January 2018

1 reference

NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.

21 January 2018

1 reference

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

21 January 2018

1 reference

High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.

21 January 2018

1 reference

Essential biochemistry and physiology of (NT-pro)BNP.

21 January 2018

1 reference

Biochemistry of B-type natriuretic peptide--where are we now?

21 January 2018

1 reference

BNP or NTproBNP? A clinician's perspective.

21 January 2018

1 reference

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.

21 January 2018

1 reference

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

21 January 2018

1 reference

Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method.

21 January 2018

1 reference

Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide.

21 January 2018

1 reference

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

21 January 2018

1 reference

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

21 January 2018

1 reference

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea

21 January 2018

1 reference

Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population

21 January 2018

1 reference

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

21 January 2018

1 reference

Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.

21 January 2018

1 reference

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure

21 January 2018

1 reference

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

21 January 2018

1 reference

Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones.

21 January 2018

1 reference

Gene expression of natriuretic peptides and their receptors type-A and -C after myocardial infarction in rats.

21 January 2018

1 reference

Natriuretic peptides and acute renal failure

21 January 2018

1 reference

N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1161/HY0102.100537

Identifiers

DOI

10.2217/BMM.12.67

1 reference

10 February 2018

PubMed ID

23227844

1 reference

10 February 2018